DGAP-News: INJEX Pharma GmbH and GenTech Laboratories LTD signed exclusive distributor agreement for INJEX, the syringe without a needle, for India
(firmenpresse) - DGAP-News: Paketeria AG / Key word(s): Contract
INJEX Pharma GmbH and GenTech Laboratories LTD signed exclusive
distributor agreement for INJEX, the syringe without a needle, for
India
25.11.2011 / 10:16
---------------------------------------------------------------------
Paketeria AG ISIN:DE000A0STYL7
Berlin, 25. November 2011
INJEX Pharma GmbH and GenTech Laboratories LTD signed exclusive distributor
agreement for INJEX, the syringe without a needle, for India
Another important milestone for INJEX Pharma to become the worldwide market
leader in 2012
INJEX Pharma based in Berlin is confirming, that the company signed an
exclusive agreement for sales and marketing of the needle free drug
delivery system INJEX 30. The partner is GENTECH Laboratories LTD, based in
Mumbai. Both parties agreed to keep information about the planned revenues
confidential.
India is worldwide the country with the second highest population in the
world with 1.2 Billion people. The gap between rich and poor people is
existing, geographic size in very special, lot of people living in areas of
high population density like Mumbai, New Delhi etc. Therefore the marketing
activities will be very focused.
Start of sales is expected for beginning of 2012. Registration of the INJEX
30 is ongoing. Both companies believe that the INJEX-system has interesting
perspectives in India, taking into consideration the strongly growing
number of patients with type II diabetes.
Mr. Viraj Gandhi, Managing Director GENTECH Laboratories LTD stated: 'India
is the diabetes capital of the world with more than 60 million diagnosed
cases as of 2010. Injex needle free delivery system will be a welcome
relief to type 1 diabetes patients who have been poking themselves with a
syringe for years. We are very excited about the Injex needle free syringe
and its potential in India'
Gandhi and his family have been involved in the Indian pharmaceutical
industry for the last 30 years. At some stage in the last few decades they
have been involved in every aspect of the pharmaceutical industry value
chain: manufacturing, marketing, distribution and retailing.
The INJEX System from the Berlin manufacturer INJEX Pharma GmbH offers the
needle free and painless subcutaneous injection of drugs. The main user
groups are diabetics, who have to inject insulin a few times every day and
for doctors and for end users for injection of growth hormones, thrombosis
prophylaxis, local Anesthetics for surgical and dental application,
vaccinations, cancer treatment etc.
INJEX Pharma GmbH shall be merged by 100% into Paketeria AG, listed at the
Frankfurt Stock Exchange, which is the main resolution on the Annual
Meeting of December 16th 2011 in Berlin. Paketeria AG will become INJEX
Pharma AG.
contact:
Andy Rösch
CEO / Managing Director
Paketeria AG / INJEX Pharma AG
Buckower Damm 114
12349 Berlin
Tel.: 030/53096768
andy.roesch(at)injex.de
www.injex.de
Dr. Ulrich Franz
Director of the Supervisory Board
Ulrich.franz(at)gmx.net
End of Corporate News
---------------------------------------------------------------------
25.11.2011 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
147669 25.11.2011
Themen in dieser Pressemitteilung:
injex-pharma-gmbh-and-gentech-laboratories-ltd-signed-exclusive-distributor-agreement-for-injex
the-syringe-without-a-needle
for-india
Unternehmensinformation / Kurzprofil:
Datum: 25.11.2011 - 10:16 Uhr
Sprache: Deutsch
News-ID 91049
Anzahl Zeichen: 4367
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 373 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: INJEX Pharma GmbH and GenTech Laboratories LTD signed exclusive distributor agreement for INJEX, the syringe without a needle, for India"
steht unter der journalistisch-redaktionellen Verantwortung von
Paketeria AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
